S8-9
(P)
ULTRASOUND MARKERS IN THE FOLLOW UP OF PYELOPLASTY
María FERNÁNDEZ-IBIETA
1
, Leonardo NORTES-CANO
2
, María José GUIRAO-PIÑERA
2
, Gerardo ZAMBUDIO-CARMONA
2
and José Ignacio RUIZ-JIMÉNEZ
2
1) Hospital C U V Arrixaca, Pediatric Surgery, Murcia, SPAIN - 2) Hospital CUV Arrixaca. Murcia. Spain, Pediatric
Surgery, Murcia, SPAIN
PURPOSE
There are few studies on the long term follow up of pyeloplasty. Is there a residual pelvis dilatation in all successful
procedures? How is the long term evolution of the sonographic parameters and measures postoperatively (PO)? In this
study, some useful sonographic parameters are highlighted to evaluate the expected evolution of renal pelvis after a
successful pyeloplasty
MATERIAL AND METHODS
We reviewed all successful pyeloplasties performed on obstructed renal pelvis with an Anterio-Posterior Diameter > 15
mm in the years 2001-2010. Ultrasound controls were made at 3 and 6 months postoperatively and then yearly
afterwards. We pretended to describe time course of hydronefrotic changes following unilateral pyeloplasties, using
three parameters: pelvic anterior-posterior diameter (APD), Pelvis/ Córtex Ratio (P/C R) and the percentage of
improvement in APD (PI-APD)
RESULTS
41 patients were included. Age at intervention ranged from 2 months to 10.3 years (mean 13 months, 83% were
operated in the first year of life). Median of follow up was 4 years (range 1-12 years) Mean APD preoperatively was 25
mm (range 16-54). At the third month PO, PI- APD was 28%. At the sixth month control, it was 51%, and remained
stable during the next consecutive yearly controls, without statistically significant variations (50%, 57%, 60%, 51%,
39%, 46%, 38%, 42%). P/C R diminished significantly already in the third month control (4.6 vs. 1.8, p=0.03). We
observed complete disappearance of hidronefrosis in 8 patients (19.5%).
CONCLUSIONS
Although early postoperative ultrasound changes occur, the ultrasound parameters remain often stable during long term
follow up. We documented the complete normalization of renal pelvis (no hydronephrosis) in one of every five patients.